Home Business FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

by admin

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.Original Article

You may also like

Leave a Comment

two + 18 =